109 related articles for article (PubMed ID: 10707945)
1. Protective features of monoclonal antibodies to Escherichia coli during experimental infection of mice with homologous and heterologous serotypes of E. coli.
Raponi G; Ghezzi MC; Lun MT; Bigotti G; Natali PG; Mancini C
J Med Microbiol; 2000 Mar; 49(3):253-260. PubMed ID: 10707945
[TBL] [Abstract][Full Text] [Related]
2. Characterisation and protective capacity of monoclonal antibodies elicited in mice against protein epitopes of antibiotic-exposed Escherichia coli.
Lun MT; Raponi G; Amatucci AM; Natali PG; Fraioli R; Mancini C
J Med Microbiol; 1997 Feb; 46(2):122-8. PubMed ID: 9060871
[TBL] [Abstract][Full Text] [Related]
3. Murine monoclonal antibody elicited with antibiotic-exposed Escherichia coli exerts protective capacity in experimental bacterial infections.
Lun MT; Amatucci AM; Raponi G; Filadoro F; Bartolazzi A; Fraioli R; Natali PG; Mancini C
J Med Microbiol; 1994 Sep; 41(3):179-83. PubMed ID: 8064837
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli.
Salles MF; Mandine E; Zalisz R; Guenounou M; Smets P
J Infect Dis; 1989 Apr; 159(4):641-7. PubMed ID: 2647860
[TBL] [Abstract][Full Text] [Related]
5. Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.
Frasa H; Benaissa-Trouw B; Tavares L; van Kessel K; Poppelier M; Kraaijeveld K; Verhoef J
Infect Immun; 1996 Mar; 64(3):775-81. PubMed ID: 8641781
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of splenic macrophage tumor necrosis factor alpha secretion in vivo by antilipopolysaccharide monoclonal antibodies.
Battafarano RJ; Burd RS; Kurrelmeyer KM; Ratz CA; Dunn DL
Arch Surg; 1994 Feb; 129(2):179-80. PubMed ID: 8304828
[TBL] [Abstract][Full Text] [Related]
7. Reactivity and protective capacity of a polyclonal antiserum derived from mice immunized with antibiotic exposed Escherichia coli.
Raponi G; Lun MT; Lorino G; Nazzari C; Gaeta A; Mancini C; Filadoro F
J Antimicrob Chemother; 1993 Jan; 31(1):117-28. PubMed ID: 8444656
[TBL] [Abstract][Full Text] [Related]
8. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies reactive with K1-encapsulated Escherichia coli lipopolysaccharide are opsonic and protect mice against lethal challenge.
Kaufman BM; Cross AS; Futrovsky SL; Sidberry HF; Sadoff JC
Infect Immun; 1986 May; 52(2):617-9. PubMed ID: 3516883
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody to endotoxin core protects mice from Escherichia coli sepsis by a mechanism independent of tumor necrosis factor and interleukin-6.
Silva AT; Appelmelk BJ; Buurman WA; Bayston KF; Cohen J
J Infect Dis; 1990 Aug; 162(2):454-9. PubMed ID: 2197338
[TBL] [Abstract][Full Text] [Related]
11. Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis.
Zisman DA; Kunkel SL; Strieter RM; Gauldie J; Tsai WC; Bramson J; Wilkowski JM; Bucknell KA; Standiford TJ
Shock; 1997 Nov; 8(5):349-56. PubMed ID: 9361345
[TBL] [Abstract][Full Text] [Related]
12. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.
Starnes HF; Pearce MK; Tewari A; Yim JH; Zou JC; Abrams JS
J Immunol; 1990 Dec; 145(12):4185-91. PubMed ID: 2124237
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of production of tumor necrosis factor by monoclonal antibodies to lipopolysaccharides.
Vacheron F; Mandine E; Lenaour R; Smets P; Zalisz R; Guenounou M
J Infect Dis; 1992 May; 165(5):873-8. PubMed ID: 1569336
[TBL] [Abstract][Full Text] [Related]
14. Role of interferon-gamma in experimental gram-negative sepsis.
Silva AT; Cohen J
J Infect Dis; 1992 Aug; 166(2):331-5. PubMed ID: 1634804
[TBL] [Abstract][Full Text] [Related]
15. Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria.
Raponi G; Keller N; Overbeek BP; Rozenberg-Arska M; Torensma R; Verhoef J
J Infect Dis; 1991 Jan; 163(1):122-7. PubMed ID: 1701816
[TBL] [Abstract][Full Text] [Related]
16. Protective activity of the antilipopolysaccharide antibodies from human cord serum.
Pontes GN; Massironi SG; Arslanian C; Friedlander-Del Nero DL; Carneiro-Sampaio MM; Nagao AT
FEMS Immunol Med Microbiol; 2006 Aug; 47(3):405-13. PubMed ID: 16872377
[TBL] [Abstract][Full Text] [Related]
17. Antibody immunotherapy of gram-negative bacterial sepsis in an immunosuppressed animal model.
Dunn DL
Transplantation; 1988 Feb; 45(2):424-9. PubMed ID: 3278438
[TBL] [Abstract][Full Text] [Related]
18. Distinct functional activities in canine septic shock of monoclonal antibodies specific for the O polysaccharide and core regions of Escherichia coli lipopolysaccharide.
Hoffman WD; Pollack M; Banks SM; Koev LA; Solomon MA; Danner RL; Koles N; Guelde G; Yatsiv I; Mouginis T
J Infect Dis; 1994 Mar; 169(3):553-61. PubMed ID: 7512609
[TBL] [Abstract][Full Text] [Related]
19. Minimal concentration of human IgM and IgG antibodies necessary to protect mice from challenges with live O6 Escherichia coli.
Massironi SM; Arslanian C; Carneiro-Sampaio MM; Pontes GN
FEMS Immunol Med Microbiol; 2011 Nov; 63(2):193-201. PubMed ID: 22077222
[TBL] [Abstract][Full Text] [Related]
20. Balance of proinflammatory and antiinflammatory cytokines in mice immunized with Escherichia coli and correlation with mortality after lethal challenge.
Raponi G; Ghezzi MC; Lun MT; Mancini C
Med Microbiol Immunol; 1998 Jun; 187(1):11-6. PubMed ID: 9749978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
